Table 1.
Characteristics | Total (N=1211) | |
---|---|---|
Age at surgery, years-Median (range) | 63 (23–88) | |
Gender, Male- N (%) | 695 | (57.5) |
Synchronous Disease- N (%) | 491 | (40.5) |
Positive nodes in primary – N (%) | ||
Yes | 727 | (60.0) |
No | 473 | (39.1) |
Unknown | 11 | (0.9) |
CEA – N (%) | ||
>200 | 119 | (9.8) |
≤200 | 936 | (77.3) |
Unknown | 156 | (12.9) |
DFI < 12 months– N (%) | 637 | (52.6) |
No. of hepatic tumors | ||
Median (range) | 2 (1–50) | |
1 | 588 | (48.6) |
2–4 | 477 | (39.4) |
5–10 | 115 | (9.5) |
>10 | 31 | (2.6) |
Size of hepatic tumor, cm- Median (range) | 4.0 (0–40) | |
Clinical Risk Score – N (%) | ||
Low (0,1,2) | 627 | (51.8) |
High (3,4,5) | 420 | (34.7) |
Unknown | 164 | (13.5) |
Extrahepatic Disease- N (%) | 88 | (7.3) |
Surgical margin – N (%) | ||
Positive | 109 | (9.0) |
Negative | 1102 | (91.0) |
Perioperative chemotherapy – N (%) | ||
Yes | 1120 | (92.5) |
No | 91 | (7.5) |
Perioperative HAIP- N (%) | ||
Yes | 348 | (28.7) |
No | 863 | (71.3) |
Vital Status at last contact – N (%) | ||
NED | 302 | (24.9) |
AWD | 35 | (2.9) |
DOD | 748 | (61.8) |
DOC | 63 | (5.2) |
DUC | 63 | (5.2) |
Abbreviations: CEA, carcinoembryonic antigen; DFI, disease-free interval; HAIP, hepatic artery infusion pump; NED, no evidence of disease; AWD, alive with disease; DOD, dead of disease; DOC, dead other cause; DUC, dead unknown cause.